Skip Nav Destination
CONTINUING MEDICAL EDUCATION (CME) QUESTIONS|
June 15, 2023
Abatacept in steroid-refractory cGVHD
CME
Blood (2023) 141 (24): 3008.
Connected Content
A related article has been published:
Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease
Citation
Abatacept in steroid-refractory cGVHD. Blood 2023; 141 (24): 3008. doi: https://doi.org/10.1182/blood.2023021044
Download citation file:
June 15 2023
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal